QuidelOrtho (QDEL) Non-Current Deferred Tax Liability (2022 - 2026)
QuidelOrtho (QDEL) reported Non-Current Deferred Tax Liability of $87.3 million for Q1 2026, up 11.64% on a YoY basis from $78.2 million in Q1 2025, and down 3.0% sequentially from $90.0 million in Q4 2025.
QuidelOrtho (QDEL) Non-Current Deferred Tax Liability (2022 - 2026) Analysis & Trends
QuidelOrtho (QDEL) has 5 years of Non-Current Deferred Tax Liability data on file, last reported at $87.3 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Deferred Tax Liability rose 11.64% year-over-year to $87.3 million; the trailing twelve-month figure through Mar 2026 stood at $87.3 million (up 11.64% YoY), and the FY2025 full-year result was $90.0 million, down 85.5% from the prior year.
- Non-Current Deferred Tax Liability retreated to $87.3 million in Q1 2026, from $90.0 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $707.4 million in Q4 2023 to a low of $73.5 million in Q1 2022.
- A 5-year average of $204.7 million and a median of $127.9 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
- Across the five-year window, Non-Current Deferred Tax Liability soared 231.8% in 2023 and sank 85.5% in 2025, its largest moves.
- Tracing QDEL's Non-Current Deferred Tax Liability over 5 years: stood at $256.4 million in 2022, then surged by 175.9% to $707.4 million in 2023, then decreased by 12.26% to $620.7 million in 2024, then slumped by 85.5% to $90.0 million in 2025, then fell by 3.0% to $87.3 million in 2026.
- Business Quant data shows QDEL's Non-Current Deferred Tax Liability at $87.3 million in Q1 2026, $90.0 million in Q4 2025, and $80.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | QuidelOrtho | 1.13 Bn | 990.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 87.30 Mn |
| Mar 29, 2026 | 87.30 Mn |
| Dec 28, 2025 | 90.00 Mn |
| Dec 28, 2025 | 90.00 Mn |
| Sep 28, 2025 | 80.10 Mn |
| Sep 28, 2025 | 80.10 Mn |
| Jun 29, 2025 | 82.80 Mn |
| Jun 29, 2025 | 82.80 Mn |
| Mar 30, 2025 | 78.20 Mn |
| Mar 30, 2025 | 78.20 Mn |
| Dec 29, 2024 | 620.70 Mn |
| Dec 29, 2024 | 620.70 Mn |
| Sep 29, 2024 | 117.20 Mn |
| Sep 29, 2024 | 117.20 Mn |
| Jun 30, 2024 | 127.90 Mn |
| Jun 30, 2024 | 127.90 Mn |
| Mar 31, 2024 | 125.60 Mn |
| Mar 31, 2024 | 125.60 Mn |
| Dec 31, 2023 | 707.40 Mn |
| Dec 31, 2023 | 707.40 Mn |